Operation Warp Speed Shortlist Not Decided Yet, Says Novavax
We’re Still In The Running, Says R&D Chief
Novavax gained a US Department of Defense contract for its vaccine candidate recently, and is confident its nanoparticle approach provides a good alternative to other technologies.
